Addex Therapeutics Ltd ADR
(ADXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,015 | -11,759 | -21,801 | -16,797 | -13,715 |
| Depreciation Amortization | 296 | 341 | 339 | 380 | 399 |
| Accounts receivable | 106 | 341 | -264 | -106 | 53 |
| Accounts payable and accrued liabilities | -1,302 | -683 | -448 | 967 | -1,691 |
| Other Working Capital | -1,395 | 238 | 165 | -653 | -1,638 |
| Other Operating Activity | -11,823 | 2,619 | 4,785 | 119 | 3,601 |
| Operating Cash Flow | $-6,104 | $-8,903 | $-17,225 | $-16,089 | $-12,991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -8 | -1 | -35 | -63 |
| Sale Of Investment | N/A | N/A | 4 | 1 | N/A |
| Other Investing Activity | 5,278 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $5,277 | $-8 | $3 | $-33 | $-63 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 274 | 6,426 | 4,760 | 17,103 | N/A |
| Common Stock Repurchased | N/A | -44 | N/A | 4,154 | 768 |
| Other Financing Activity | -154 | -518 | -1,509 | -3,310 | -719 |
| Financing Cash Flow | $119 | $5,864 | $3,251 | $17,946 | $50 |
| Exchange Rate Effect | 113 | -398 | -206 | 134 | -692 |
| Beginning Cash Position | 4,391 | 7,750 | 21,466 | 20,454 | 33,637 |
| End Cash Position | 3,796 | 4,306 | 7,290 | 22,413 | 19,940 |
| Net Cash Flow | $-595 | $-3,444 | $-14,176 | $1,958 | $-13,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,104 | -8,903 | -17,225 | -16,089 | -12,991 |
| Capital Expenditure | -1 | -8 | -1 | -35 | -63 |
| Free Cash Flow | -6,105 | -8,910 | -17,225 | -16,123 | -13,055 |